Brain cancer patients test CBD for anxiety relief
NCT ID NCT05753007
Summary
This study tested whether a hemp-derived, high-CBD product could help reduce anxiety, pain, and sleep problems in adults newly diagnosed with glioblastoma, a serious brain cancer. Participants were randomly assigned to receive either the CBD product or a placebo for 8 weeks while undergoing standard cancer treatment. The goal was to see if CBD could improve their quality of life by easing these difficult symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California San Francisco Brain Tumor Center
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.